| Reduced Risk Status: |
|
| IPM Compatibility: |
|
| Reasons for need: |
FOR TRACKING INT'L RESIDUE TRIALS IN KENYA, UGANDA AND TANZANIA; COLOMBIA AND PERU ADDED, AND NO MENTION OF TANZANIA: 07/21;
|
| Requesting State(s): |
HQ:SAMOIL ;
|
| PCR Use Pattern: |
|
| EPA Default Residue Trials: |
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
THERE IS NO OFFICIAL REQUEST ASSOCIATED WITH THESE INT'L TRIALS: 07/21; THIS PR# IS FOR THE STUDY BEING CONDUCTED IN PERU.; SEE PR#’S 11821, 13275, 13276 FOR ASSOCIATED STUDIES.:07/21; THE STUDY UNDER THIS PR SHALL ALSO INCLUDE COLUMBIAN FIELD TRIALS: 09/21;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|